| Current United Kingdom & Ireland Articles |
|---|
 |
Chemistry World
May 1, 2013
Emma Stoye |
Wellcome Trust announces new head Jeremy Farrar, professor of Tropical Medicine and Global Health at Oxford University, has been named as the next director of the Wellcome Trust.   |
Chemistry World
April 29, 2013
Maria Burke |
Finishing line in sight for libel reform Parliament has agreed a new libel law. The landmark piece of legislation, which applies to England and Wales, should provide more protection for individuals, including scientists, newspapers and broadcasters, who criticize big companies. |
Chemistry World
April 23, 2013
Emma Stoye |
Invest in research or be left behind, UK academies warn The UK's four national academies have called on the government to increase investment in research over the next decade or risk being overtaken by international competitors. |
Chemistry World
April 23, 2013
Phillip Broadwith |
Ireland picks preferred drugs Ireland has become the first country to identify lists of 'preferred drugs'. Ensuring patients use the best value-for-money drugs could save patients and taxpayers millions of euros, says the Irish Health Service Executive. |
Chemistry World
April 19, 2013
Phillip Broadwith |
Objections raised to GSK pay-for-delay deals The UK Office of Fair Trading has said that GlaxoSmithKline's deals to delay generic drugs infringed competition laws. |
Chemistry World
April 9, 2013
Emma Stoye |
Drug restrictions delay magic mushroom trial The first clinical trial to explore the antidepressant effects of psilocybin, the hallucinogenic component of magic mushrooms, has been delayed by EU and UK drug regulations. |
Chemistry World
April 4, 2013
Joe Connor |
An artful solution to scientist shortfall There has been much attention given recently to concerns regarding the overproduction of science graduates in the United Kingdom. |
Chemistry World
April 2, 2013
Laura Howes |
Funding boost for PhDs UK research funder, the Engineering and Physical Sciences Research Council, has announced 84.2 million for doctoral training grants, stipends awarded to institutions to fund PhD students. |
Chemistry World
April 2, 2013
Bibiana Campos Seijo |
More job cuts... The news came in that AstraZeneca is to invest 330 million pounds in a new strategic R&D center and global headquarters in Cambridge, UK. Unfortunately, there is also a negative angle to this story. |
| There are 784 old articles available for this category. |
